Adewoye EO, Taiwo VO, Olayioye FA. 2009. Anti-oxidant and anti-hyperglycemic activities of musa sapientum root extracts in alloxan-induced diabetic rats. Afr J Med Med Sci, 38:109-117.
Barrett JE. 1991. Animal behavior models in the analysis and understanding of anxiolytic drugs acting at serotonin receptors. In: Olivier B, Mos J, Slangen JL, editors. Animal models in psychopharmacology. Switzerland: Basel Birkhauser Verlag, pp. 37–52.
Cryan JF, Sweeney FF. 2011.The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol, 164:1129-1161.
Dikshit P, Tyagi MK, Shukla K, Sharma S, Gambhir JK, Shukla R. 2011. Hepatoprotective effect of stem of Musa sapientum Linn in rats intoxicated with carbon tetrachloride. Ann Hepatol, 10:333-339.
Emhan A, Selek S, Bayazıt H, Fatih Kİ, Katı M, Aksoy N. 2015. Evaluation of oxidative and antioxidative parameters in generalized anxiety disorder. Psychiatry Res, 230:806-810.
Goel RK, Sairam K, Rao CV. 2001. Role of gastric antioxidant and anti-Helicobactor pylori activities in antiulcerogenic activity of plantain banana (Musa sapientum var. paradisiaca). Indian J Exp Biol, 39:719-722.
Grases G, Colom MA, Fernandez RA, Costa-Bauzá A, Grases F. 2014. Evidence of higher oxidative status in depression and anxiety. Oxid Med Cell Longev, doi: 10.1155/2014/430216.
Hajhashemi V, Rabbani M, Ghanadi A, Davari E. 2010. Evaluation of antianxiety and sedative effects of essential oil of Ducrosia anethifolia in mice. Clinics, 65:1037-1042.
Kessler RC. 2007. The global burden of anxiety and mood disorders: putting the European Study of the Epidemiology of Mental Disorders (ESEMeD) findings into perspective. J Clin Psychiatry,68:10-19.
Krolow R, Arcego DM, Noschang C, Weis SN, Dalmaz C. 2014. Oxidative imbalance and anxiety disorders. Curr Neuropharmacol, 12:193-204.
Kumar GP, Khanum F. 2012. Neuroprotective potential of phytochemicals. Pharmacogn Rev, 6:81-90.
Michel Bourin. 2015. Animal models for screening anxiolytic-like drugs: a perspective. Dialogues Clin Neurosci, 17:295-303.
Pellow S, File S. 1986. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav, 24:525- 529
Pereira A, Maraschin M. 2015. Banana (Musa spp) from peel to pulp: ethnopharmacology, source of bioactive compounds and its relevance for human health. J Ethnopharmacol, 160:149-163.
Reddy AJ, Handu SS, Dubey AK, Mediratta PK, Shukla R, Ahmed QM. 2016. Effect of Musa sapientum Stem Extract on Animal Models of Depression. Pharmacogn Res, 8:249-252.
Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB. 2008. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry, 30:208-225.
Sajja VS, Hubbard WB, VandeVord PJ. 2015. Subacute Oxidative Stress and Glial Reactivity in the Amygdala are Associated with Increased Anxiety Following Blast Neurotrauma. Shock, Suppl 1:71-78.
Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, Przegaliński E, Pera J, Filip M. 2015. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep, 67:569-580.
Tsai MC, Huang TL. 2016. Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder. Psychiatry Res, 235:38-42.
Turner R. 1965. Screening Methods in Pharmacology. Vol. 1. New York: Academic Press, p. 26.
Trebaticka J, Durackova Z. 2015. Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy? Oxid Med Cell Longev, doi:10.1155/2015/248529